Virologists unravel mystery of late C20th gibbon leukaemia outbreak

November 17, 2016

The mystery of an outbreak of lymphoma and leukaemia in gibbon colonies in the US, Bermuda and Thailand in the late 1960s and early 1970s has been solved by animal disease detectives at The University of Nottingham.

The virology experts from the University's Vet School have carried out an investigation into the cancer outbreak which was caused by the gibbon ape leukaemia retrovirus (GALV). They found it was most likely caused inadvertently by the unregulated international trading of gibbons and laboratory work on viruses in US military and other medical research facilities.

In a paper published in Mammal Review, the researchers crucially also found no evidence of infection in current populations of captive gibbons - an endangered species - and no evidence that the virus is still a threat.

Lecturer in Veterinary Cellular Microbiology, Dr Rachael Tarlinton, explained: "We thought the strange outbreak of gibbon ape leukaemia and lymphoma in certain colonies fifty years ago was an enigma worth investigating, not least to see if we could find any evidence that GALV is still a problem among live populations today.

"Our review brings together published literature and laboratory records from early research into GALV which is a known contaminant of laboratory cell culture. We also analysed correspondence about the transportation of gibbons during the 60s and 70s, laboratory and zoological records to discover the origin of the retrovirus and how it could have been transmitted."

The investigation found that lymphoma and leukaemia were not recorded in gibbons until the 1960s when cases were reported in gibbons in or imported to the US from south-east Asia. In 1969 cases of malignant lymphoma were reported in a single colony of white-handed gibbons in a US military research facility in Bangkok, Thailand and were at the time attributed to an unknown infectious agent. This agent was identified as GALV retrovirus, which was not native to the species, two years later when five more gibbons in the same colony were diagnosed with leukaemia.

The researchers found that the virus was almost certainly inadvertently transmitted to the gibbons from rodents by medical researchers working on human diseases such as malaria and dengue fever.

The team also found that the unregulated trading of research gibbons at the time may have even caused GALV infection found in a monkey kept as a pet in a San Francisco apartment which went on to develop lymphosarcoma.

Co-investigator, Dr Katherine Brown, now at Oxford University, said: "When we analysed the genetic sequence of the retroviruses in these animals it told us the same information as the historical documents, that they have come from the same source, which is what we expected.

"It is very reassuring that we found no evidence that, although this was a serious outbreak 50 years ago, we now know how it came about and that it was a single event exacerbated by human intervention. The risk of it ever happening again is now thankfully very low".
-end-


University of Nottingham

Related Lymphoma Articles from Brightsurf:

Oncotarget: An integrative microenvironment approach for follicular lymphoma
Oncotarget Volume 11, Issue 33 features Figure 8, ''Haplotype estimates in follicular lymphoma patients,'' by Assis-Mendonça, et al. which reported that the authors tested associations between SNPs, clinicopathological features and TME composition, and proposed survival models in R-CHOP/R-CVP-treated patients.

Novel Radioimmunotherapy Reverses Resistance to Commonly Used Lymphoma Drug
A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug, rituximab, according to research published in the October issue of The Journal of Nuclear Medicine.

A new immunotherapeutic agent for children and adolescents with advanced lymphoma
The excellent results of the phase III international paediatric study, Inter-B-NHL ritux 2010, have been published in the New England Journal of Medicine.

Lymphoma's different route revealed
Researchers at the MDC observe the very early stages of blood vessel development in lymph node tumors.

Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma
Researchers from the University of Tsukuba have shown by in vivo experimentation on a mouse model that angioimmunoblastic T-cell lymphoma is highly dependent on T-Cell Receptor Signaling.

Suspect eliminated as a therapeutic target in B cell lymphoma
Australian researchers have narrowed the focus on which survival proteins are important for the survival of B cell lymphomas, eliminating the protein BCL-W from the 'suspect list'.

New factor in the development of childhood lymphoma
The immune system is highly complex and a detailed understanding of many underlying mechanisms is still lacking.

Antibiotics can inhibit skin lymphoma
New research from the LEO Foundation Skin Immunology Research Center at the University of Copenhagen shows, surprisingly, that antibiotics inhibit cancer in the skin in patients with rare type of lymphoma.

Association of BRCA2 mutations with risk of childhood lymphoma
This research letter reports on the association of BRCA2 gene mutations and potential risk for pediatric or adolescent lymphoma.

Why Hodgkin's lymphoma cells grow uncontrollably
Although classical Hodgkin's lymphoma is generally easily treatable today, many aspects of the disease still remain a mystery.

Read More: Lymphoma News and Lymphoma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.